Simplex Trading’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Simplex Trading’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,900	Closed	-$2K	–	11163
2022 Q3	$2K	Sell	13,900 -6,600	-32%	-$6.09K	﹤0.01%	9464
2022 Q2	$23K	Buy	20,500 +18,380	+867%	+$30.3K	﹤0.01%	7469
2022 Q1	$10K	Sell	2,120 -1,233	-37%	-$7.75K	﹤0.01%	8929
2021 Q4	$18K	Buy	3,353 +1,100	+49%	+$9.35K	﹤0.01%	8523
2021 Q3	$37K	Hold	2,253	–	–	﹤0.01%	7900
2021 Q2	$38K	Buy	2,253 +2,228	+8,912%	+$42.2K	﹤0.01%	7986
2021 Q1	$65K	Buy	+25	New	+$1.14K	﹤0.01%	6304

Simplex Trading's EVFM Position: Q4 2022 in Review

Simplex Trading sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 546 shares.

Simplex Trading first reported a position in EVFM in Q2 2020 and held it in 10 quarters. The position peaked at $41K in Q2 2022. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

Simplex Trading reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 546 Evofem Biosciences, Inc. Common Stock shares in Q4 2022.
Simplex Trading first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Simplex Trading's Evofem Biosciences, Inc. Common Stock position peaked at $41K in Q2 2022.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.